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Particularly in the UK, the Medicines and Health
Regulatory Agency (MHRA) products strategy
(2012 – 2015)3 specifies that falsified finished
medicines products seized in the UK have one or
more of the following: ‘No API, wrong API, too
much API, too little API, always contain a range
of unknown impurities, may use inappropriate
excipients and often fail to dissolve at the correct
rate when taken’. Consequently, manufacturer
authorisation holders are required to verify the
compliance of APIs with respect to good
manufacturing practice and good distribution
practices, and the suitability of the excipients for
medicinal use. This will introduce a high demand
of API / excipients (coming from outside the EU)
authentication in a short time frame. This
stimulates the need for rapid screening
techniques for identification / authentication of
raw materials.
Handheld Raman spectroscopy has been
recognised as a powerful tool in pharmaceutical
analysis particularly for raw material identity
testing1,4. The advantages of handheld Raman
spectroscopy include: simplicity, rapidity,
portability and ease of use by non-skilled
personnel5-7. In addition, handheld Raman
spectroscopy offers a non-destructive measure -
ment of materials regarding of their physical
state (solid, semi-solid, liquid)8. Moreover,
handheld Raman spectroscopy can measure 
the sample within its container whether glass 
or plastic7.
Conventional Raman spectroscopy involves
the use of 785 nm laser power. Although this
laser power offers sensitivity in raw material
identification, it has many disadvantages9. 
It introduces interferences due to fluorescence
from Raman inactive materials such as cellulose
and lactose. This affects the accuracy of identi -
fication of the material measured. In general,
pharmaceutical excipients are Raman inactive,
whereas pharmaceutical active ingredients
(APIs) are Raman active8,10. However, the use of a
longer wavelength laser (such as 1064 nm) can
reduce and / or eliminate the fluorescence
interference yet decreases the sensitivity10.
The aim of this work is to compare the use 
of 785 nm to 1064 nm laser excitation wave -
length for the accuracy of identification of 
raw materials.
Experimental
A total of 25 raw materials were measured
through glass vials and included 13 APIs and 12
excipients. The APIs included Benzocaine (BEN);
caffeine (CAF); indomethacin (IND); lidocaine
hydrochloride (LID); nicotinamide (NIC);
paracetamol (PAR); phenacetin (PHE); procaine
hydrochloride (PRO); promethazine (PROM);
quinine sulfate (QUI); sildenafil citrate (SIL);
taurine (TAU) and theophylline (THE). In
addition, the excipients included alginate
sodium (ALG); dextrose monohydrate (DEX);
hydroxyl ethyl cellulose (HEC); lactose
monohydrate (LAC); maize starch (MAI);
mannitol (MAN); microcrystalline cellulose
Raw material identification is a significant and crucial stage in validating the authenticity of pharmaceutical products as
pharmaceutical manufacturers have been recently moving into 100 per cent testing of incoming raw material1. The Falsified
Medicines Directive (FMD) that came into light in July 2013 assured tough rules on the assessment of active pharmaceutical
ingredients (APIs) and excipients2. 
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(MCC); polyvinyl pyrrolidone (PVP); saccharin
sodium (SAC); sodium benzoate (SODB); sucrose
(SUC) and talc (TAL).
Three spectra were collected from each vial
using two handheld Raman spectrometers with
laser excitation wavelengths of 785 nm and
1064 nm respectively. Both instruments were
equipped with a thermoelectric cooled (TE)
charged coupled device (CCD) detector.
The raw spectra were exported to Matlab
R2007a where spectral quality and identification
potential of the instruments were evaluated. The
spectral quality was evaluated by comparing 
the number of peaks (n), maximum peak intensity
and position and signal to noise ratio (S/N). The
identification potential of the instruments were
evaluated using correlation in wavelength space
(CWS) and principal component analysis (PCA)
were applied. The optimum value for the
correlation coefficient (r) taken was 0.95.
Results and discussion
Both instruments offered a rapid and simple
approach to identification of raw materials. Thus,
a Raman spectrum could be obtained within a
few seconds to one-minute intervals. This is
advantageous when measuring large number of
samples in the pharmaceutical industry such as
raw materials identification. In addition, the
simplicity in sample measurement makes 
these instruments easy to be used by non-
skilled personnel.
Spectral quality
The spectral quality varied between both
instruments where the 785 nm instrument
showed more fluorescence. This depended to a
degree on the type of raw material measured. In
general, APIs showed less fluorescence and
higher Raman scattering than excipients when
measured using the 785 nm instrument. In
addition, the scattering due to glass vials was
observed in some spectra. However, this did not
affect the spectral quality of the raw material
measured. Figure 1 shows the Raman spectra of
PAR (API) and SAC (excipient) measured using
the two handheld Raman instruments.
Spectral quality was evaluated by taking
four parameters into consideration (Table 1 and
Table 2, page 28). These included: the number of
peaks, Raman scattering intensity, spectral
range and S/N ratio. Based on these four criteria,
the Raman activity of the material measured was
classified as low, medium, strong or very strong.
The spectral range of scattering obtained
using both instruments was between 250 – 2000
cm-1. APIs showed stronger Raman activity than
excipients in relation to the number of peaks,
maximum scattering intensity and S/N ratio. 
For the Raman spectra obtained using the
785 nm instrument, three APIs showed very
strong Raman scattering. These were BEN, NIC
and PAR and had S/N ratio of 118, 140 and 142
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Table 1 Spectral quality of raw materials measured using the Raman instrument equipped with 785 nm laser power
Raw
material Maximum Peak Maximum Peak S/N Raman
number Raw material n position (cm-1) intensity ratio activity
X1 Alginate sodium 8 566.8 6479 14.8 Medium
X2 Benzocaine 12 164 39670 118 Very strong
X3 Caffeine 14 558.1 32130 54.5 Strong
X4 Dextrose monohydrate 17 1331 4618 33.5 Strong
X5 Hydroxy ethyl cellulose 7 1079 5231 11.3 Medium
X6 Indomethacin 5 1592 19190 11.25 Medium
X7 Lactose 17 1087 6411 34 Strong
X8 Lidocaine hydrochloride 7 633.2 2861 26 Medium
X9 Maize starch 12 464.4 5261 30.5 Strong
X10 Mannitol 15 875 19860 146 Strong
X11 MCC 7 1092 9917 22 Medium
X12 NIC 13 1039 47700 140 Very strong
X13 PAR 20 8575 23630 142 Very strong
X14 PHE 24 1327 15850 72 Strong
X15 PRO 15 1261 23250 68 Strong
X16 PROM 17 1039 19810 73 Strong
X17 PVP 14 1426 4116 60 Strong
X18 QUI 12 1362 15870 62 Strong
X19 SAC 16 7011 53550 67 Strong
X20 SIL 15 1575 23580 70 Strong
X21 SODB 10 1002 45600 68 Strong
X22 SUC 7 556.9 8036 17.5 Medium
X23 TAL 6 673.1 13010 10 Weak
X24 TAU 17 1029 23220 69 Strong
X25 THE 17 547 30470 63 Strong
Figure 1 Raman spectra of (a) paracetamol measured using the 1064 nm instrument, (b) paracetamol 
measured using the 785 nm instrument, (c) saccharin measured using the 1064 nm instrument and 
(d) saccharin measured using the 785 nm instrument
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respectively (Table 1, page 26). In addition, eight
APIs showed strong Raman scattering and
included CAF, PHE, PRO, PROM, QUI, SIL, TAU 
and THE. These had S/N ratios in the range of
54.5 to 73. Only two APIs showed medium
Raman scattering and had S/N ratios of 34 (IND)
and 30.5 (LID); whereas no APIs showed weak
Raman scattering. The APIs which showed
medium Raman scattering had the lowest
number of peaks (Table 1, page 26). In this
respect, IND and LID had five and seven peaks
respectively. On the other hand, the highest
number of peaks was observed for PHE and was
24 peaks. In addition, the maximum Raman
scattering intensity of APIs ranged from 2861 to
47700 arbitrary units observed for LID and PHE
respectively. This spectral range was wider 
than that obtained from the spectra using the
1064 nm instrument. Thus, the maximum
Raman scattering intensity (for APIs) obtained
through the 1064 nm instrument was ob-
served for BEN and was 34670 arbitrary units
(Table 2). Unlike the 785 nm instrument
spectrum, BEN spectrum in this case showed
medium Raman scattering and had S/N ratio 
of 15.5. For all APIs, the 1064 nm instrument
showed lower S/N ratios, less number of peaks
and lower scattering intensities. Whereas no API
showed very strong Raman scattering, nine 
APIs showed strong Raman scattering and were:
CAF, IND, NIC, PAR, PHE, PROM, SIL, TAU and THE.
These had S/N ratios in the range of 31 (IND) to
71 (PHE), and maximum peak intensities in the
range of 14720 (PROM) to 26980 (TAU). Also, 
the number of peaks of these eight APIs varied
between 14 (THE) and 21 (CAF and PAR) peaks.
The remaining four APIs showed medium
Raman scattering and included BEN, LID, 
PRO and QUI. These had S/N ratios of 15.5, 22.3, 
18 and 12 respectively. Moreover, the number of
peaks and maximum scattering intensities for
these four APIs ranged from 13 – 17 peaks and
8856 – 34670 arbitrary units respectively. 
Similarly, the excipients spectra showed
stronger Raman activity with the 785 nm
instrument. Thus, seven excipients had strong
Raman activity and were: DEX, LAC, MAI, MAN,
PVP, SAC and SODB. These excipients had S/N
ratios in the ratio of 30.5 – 146 (Table 1, page 26).
In addition, four excipients showed medium
Raman activity (ALG, HEC, MCC and SUC) and
only one excipient showed weak Raman activity
(TAL). The minimum number of peaks observed
for excipients was six (TAL) and the maximum
was 17 (LAC). Moreover, the maximum peak
intensity ranged from minimum of 4116 arb -
itrary units (PVP) to a maximum of 53550
arbitrary units (SAC). Both SAC and PVP had
strong Raman activity which was explained by
the high noise in SAC spectrum, along with the
high signal. On the other hand, the 1064 nm
instrument showed lower number of peaks,
peak intensities and S/N ratios. These ranged
between 7 (TAL) – 16 (LAC), 1701 (ALG) – 23020
(SODB) arbitrary units, and 10 (ALG) – 69 (SODB)
respectively. In this respect, only three excipients
had strong Raman activity when measured by
the 1064 nm instruments and were MAN, SAC
and SODB. These three excipients had S/N ratios
of 33.5, 61, 69 and maxima peak intensities of
9326, 2242 and 23220 arbitrary units
respectively. In addition, two excipients had
weak Raman activity and were ALG (S/N = 10)
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Table 2 Spectral quality of raw materials measured using the Raman instrument equipped with 1064 nm laser power
Raw
material Maximum Peak Maximum Peak S/N Raman
number Raw material n position (cm-1) intensity ratio activity
F1 Alginate sodium 9 1410 1701 10 Weak
F2 Benzocaine 13 1278 34670 15.5 Medium
F3 Caffeine 21 564 21790 61 Strong
F4 Dextrose monohydrate 14 518 3529 13.25 Medium
F5 Hydroxy ethyl cellulose 14 555 5487 12.6 Medium
F6 Indomethacin 17 1584 16790 31 Strong
F7 Lactose 16 356 9997 15.25 Medium
F8 Lidocaine hydrochloride 19 1449 8856 22.3 Medium
F9 Maize starch 10 480 3783 12.2 Medium
F10 Mannitol 13 875 9326 33.5 Strong
F11 MCC 8 1098 7672 22.3 Medium
F12 NIC 11 1033 20110 50 Strong
F13 PAR 21 858 25050 62 Strong
F14 PHE 18 1612 13600 71 Strong
F15 PRO 18 1255 30040 18 Medium
F16 PROM 13 1033 14720 70 Strong
F17 PVP 15 1425 3110 15.25 Medium
F18 QUI 12 1359 17060 12 Medium
F19 SAC 15 1702 2242 61 Strong
F20 SIL 17 1569 23020 32.5 Strong
F21 SODB 10 998 23220 69 Strong
F22 SUC 10 539 2410 10.3 Weak
F23 TAL 7 675 7064 21.3 Medium
F24 TAU 17 1033 26980 67 Strong
F25 THE 14 555 15230 56.5 Strong
Figure 2 Correlation map of the raw Raman spectra measured using (a) the 785 nm instrument and (b) the 
1064 nm instrument of: (1) ALG, (2) BEN, (3) CAF, (4) DEX, (5) HEC, (6) IND, (7) LAC, (8) LID, (9) MAI, (10) MAN, (11)
MCC, (12) NIC, (13) PAR, (14) PHE, (15) PRO, (16) PROM, (17) PVP, (18) QUI, (19) SAC, (20) SIL, (21) SODB, (22) SUC, 
(23) TAL, (24) TAU and (25) THE
assi epr513_Layout 1  18/10/2013  10:07  Page 3
and SUC (S/N = 10.3). These two excipients had
maxima peak intensities of 1701 and 2410
arbitrary units respectively. In addition, the
remaining nine excipients had medium Raman
activity and included: DEX, HEC, LAC, MAI, 
MCC, PVP and TAL. The S/N ratios of these
excipients ranged from 12.2 – 33.5, and the
maxima Raman intensities ranged from 3110 
– 9997 arbitrary units.
Identification of raw material
The identification of raw materials using both
instruments was evaluated using CWS and 
PCA algorithms. 
For the CWS algorithm, the r values of the
mean spectra of the 25 raw materials (APIs and
excipients) were compared. In this respect, an r
value above 0.95 indicated strong similarity;
whereas a lower r value indicated dissimilarity.
The results of CWS were visualised as a
correlation map, where a green colour indicated
an r > 0.95. Otherwise, a blue colour was
observed. Figure 2 (page 28) shows the
correlation map obtained from the spectra
measured using (a) 785 nm instrument and (b)
1064 nm instrument of: (1) ALG, (2) BEN, (3) CAF,
(4) DEX, (5) HEC, (6) IND, (7) LAC, (8) LID, (9) MAI,
(10) MAN, (11) MCC, (12) NIC, (13) PAR, (14) PHE,
(15) PRO, (16) PROM, (17) PVP, (18) QUI, (19) SAC,
(20) SIL, (21) SODB, (22) SUC, (23) TAL, (24) TAU
and (25) THE respectively. In this respect, green
colour was expected among the spectra of the
same raw material and blue colour between
spectra of different material. This was observed
among spectra measured with the 1064 nm
instrument (Figure 2b, page 28). On the other
hand, the spectra measured using the 785 nm
instrument showed green colour among spectra
of five different excipients: ALG, HEC, MCC, SUC
and TAL. The mismatches were as follows: ALG
against MCC (r = 0.97), ALG against HEC (r =
0.96), ALG against SUC (r = 0.96), HEC against
MCC (r = 0.96) and SUC against TAL (r = 0.97). 
This may be due to interferences from fluor -
escence encountered in the Raman spectra of
these excipients.
Consequently, PCA was applied to these five
excipients’ Raman spectra measured using both
the 785 and 1064 nm instruments. Figure 3
shows the PCA scores plot of the Raman spectra
obtained using both instruments. In both cases,
discrimination was observed among the five
excipients. However, the 785 nm instrument
showed more accurate identification between
individual excipients scores (Figure 3a). In this
respect, HEC and talc score showed type I error
with one score distinct from the other two
scores in both cases. Likewise, type I error was
observed between PCA scores of ALG, MCC, SUC
and TAL when measured using the 1064 nm
instrument (Figure 3b). 
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Figure 3 PCA scores plot the Raman spectra of ALG (blue), HEC (red), MCC (green), SUC (magenta) and TAL (cyan)
measured using (a) the 785 nm instrument and (b) the 1064 nm handheld Raman spectrometers
Figure 4 PCA scores plot of the combined data of ALG (blue), HEC (red), MCC (green), SUC (magenta) and TAL
(cyan) obtained from both the 785 nm and the 1064 nm handheld Raman spectrometers
Figure 5 PCA loading plot of the combined data obtained from both the 785 nm instrument and the 1064 nm
handheld Raman spectrometers
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However, this was overcome when the PCA
scores from the individual PCAs of the Raman
spectra obtained using both instruments were
combined. Consequently, the scores of the first
three PCs obtained from each instrument were
used as variables to construct the new PCA.
Figure 4 (page 30) shows the combined 
PCA scores of the five excipients. Four of these
excipients showed accurate identification and
were: ALG, MCC, SUC and TAL. On the other
hand, type I error was encountered only among
one HEC score. The loadings of the combined
PCA (785 and 1064 nm) showed contribution
from both individual PCAs (Figure 5, page 30).
This showed that the use of both instruments
gave more accurate identification.
Conclusion
Handheld Raman spectroscopy offered a 
simple, rapid and non-destructive approach 
for identification of raw materials. The use 
of a 785 nm laser showed higher sensitivity 
and better spectral quality despite the fluor -
escence and glass interference in some cases.
However, the fluorescence encountered 
from these spectra affected the accuracy of
identification of raw material. The use of a 
1064 nm laser showed better identification 
due to less fluorescence encountered in 
the spectra. However, combining the data
obtained from both instruments gave more
accurate identification of raw materials.
Consequently, the use of both 785 nm and 1064
nm lasers in unison will be a better option for
raw material identification.
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